[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Inflammatory Bowel Disease Market Report 2018

January 2018 | 97 pages | ID: U80E8F65B21EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Inflammatory Bowel Disease market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Inflammatory Bowel Disease in these regions, from 2013 to 2025 (forecast).
United States Inflammatory Bowel Disease market competition by top manufacturers/players, with Inflammatory Bowel Disease sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Abbvie
  • Merck
  • Abbott Laboratories
  • Biogen Idec
  • Janssen Pharmaceuticals
  • Merck & Company
  • Mitsubishi Tanabe
  • Salix Pharmaceuticals
  • Genentech
  • Shire
  • UCB
  • Akebia Therapeutics
  • Amgen
  • ChemoCentryx
  • Novartis
  • Boehringer Ingelheim
  • Celltrion
  • Novo Nordisk
  • Ferring Pharmaceuticals
  • Galapagos
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • 5-ASA
  • Antibiotics
  • Immunomodulators
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Inflammatory Bowel Disease Market Report 2018

1 INFLAMMATORY BOWEL DISEASE OVERVIEW

1.1 Product Overview and Scope of Inflammatory Bowel Disease
1.2 Classification of Inflammatory Bowel Disease by Product Category
  1.2.1 United States Inflammatory Bowel Disease Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Inflammatory Bowel Disease Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 5-ASA
  1.2.4 Antibiotics
  1.2.5 Immunomodulators
  1.2.6 Other
1.3 United States Inflammatory Bowel Disease Market by Application/End Users
  1.3.1 United States Inflammatory Bowel Disease Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Other
1.4 United States Inflammatory Bowel Disease Market by Region
  1.4.1 United States Inflammatory Bowel Disease Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Inflammatory Bowel Disease Status and Prospect (2013-2025)
  1.4.3 Southwest Inflammatory Bowel Disease Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Inflammatory Bowel Disease Status and Prospect (2013-2025)
  1.4.5 New England Inflammatory Bowel Disease Status and Prospect (2013-2025)
  1.4.6 The South Inflammatory Bowel Disease Status and Prospect (2013-2025)
  1.4.7 The Midwest Inflammatory Bowel Disease Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Inflammatory Bowel Disease (2013-2025)
  1.5.1 United States Inflammatory Bowel Disease Sales and Growth Rate (2013-2025)
  1.5.2 United States Inflammatory Bowel Disease Revenue and Growth Rate (2013-2025)

2 UNITED STATES INFLAMMATORY BOWEL DISEASE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Inflammatory Bowel Disease Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Inflammatory Bowel Disease Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Inflammatory Bowel Disease Average Price by Players/Suppliers (2013-2018)
2.4 United States Inflammatory Bowel Disease Market Competitive Situation and Trends
  2.4.1 United States Inflammatory Bowel Disease Market Concentration Rate
  2.4.2 United States Inflammatory Bowel Disease Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Inflammatory Bowel Disease Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INFLAMMATORY BOWEL DISEASE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Inflammatory Bowel Disease Sales and Market Share by Region (2013-2018)
3.2 United States Inflammatory Bowel Disease Revenue and Market Share by Region (2013-2018)
3.3 United States Inflammatory Bowel Disease Price by Region (2013-2018)

4 UNITED STATES INFLAMMATORY BOWEL DISEASE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Inflammatory Bowel Disease Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Inflammatory Bowel Disease Revenue and Market Share by Type (2013-2018)
4.3 United States Inflammatory Bowel Disease Price by Type (2013-2018)
4.4 United States Inflammatory Bowel Disease Sales Growth Rate by Type (2013-2018)

5 UNITED STATES INFLAMMATORY BOWEL DISEASE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Inflammatory Bowel Disease Sales and Market Share by Application (2013-2018)
5.2 United States Inflammatory Bowel Disease Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES INFLAMMATORY BOWEL DISEASE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Abbvie
  6.2.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbvie Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biogen Idec
  6.5.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biogen Idec Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Janssen Pharmaceuticals
  6.6.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Janssen Pharmaceuticals Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Merck & Company
  6.7.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck & Company Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Mitsubishi Tanabe
  6.8.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mitsubishi Tanabe Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Salix Pharmaceuticals
  6.9.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Salix Pharmaceuticals Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Genentech
  6.10.2 Inflammatory Bowel Disease Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Genentech Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Shire
6.12 UCB
6.13 Akebia Therapeutics
6.14 Amgen
6.15 ChemoCentryx
6.16 Novartis
6.17 Boehringer Ingelheim
6.18 Celltrion
6.19 Novo Nordisk
6.20 Ferring Pharmaceuticals
6.21 Galapagos

7 INFLAMMATORY BOWEL DISEASE MANUFACTURING COST ANALYSIS

7.1 Inflammatory Bowel Disease Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Inflammatory Bowel Disease

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Inflammatory Bowel Disease Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Inflammatory Bowel Disease Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INFLAMMATORY BOWEL DISEASE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Inflammatory Bowel Disease Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Inflammatory Bowel Disease Sales Volume Forecast by Type (2018-2025)
11.3 United States Inflammatory Bowel Disease Sales Volume Forecast by Application (2018-2025)
11.4 United States Inflammatory Bowel Disease Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Inflammatory Bowel Disease
Figure United States Inflammatory Bowel Disease Market Size (MT) by Type (2013-2025)
Figure United States Inflammatory Bowel Disease Sales Volume Market Share by Type (Product Category) in 2017
Figure 5-ASA Product Picture
Figure Antibiotics Product Picture
Figure Immunomodulators Product Picture
Figure Other Product Picture
Figure United States Inflammatory Bowel Disease Market Size (MT) by Application (2013-2025)
Figure United States Sales Market Share of Inflammatory Bowel Disease by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Inflammatory Bowel Disease Market Size (Million USD) by Region (2013-2025)
Figure The West Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2025)
Figure United States Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Inflammatory Bowel Disease Market Major Players Product Sales Volume (MT) (2013-2018)
Table United States Inflammatory Bowel Disease Sales (MT) of Key Players/Suppliers (2013-2018)
Table United States Inflammatory Bowel Disease Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Inflammatory Bowel Disease Sales Share by Players/Suppliers
Figure 2017 United States Inflammatory Bowel Disease Sales Share by Players/Suppliers
Figure United States Inflammatory Bowel Disease Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Inflammatory Bowel Disease Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Inflammatory Bowel Disease Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Inflammatory Bowel Disease Revenue Share by Players/Suppliers
Figure 2017 United States Inflammatory Bowel Disease Revenue Share by Players/Suppliers
Table United States Market Inflammatory Bowel Disease Average Price (USD/Kg) of Key Players/Suppliers (2013-2018)
Figure United States Market Inflammatory Bowel Disease Average Price (USD/Kg) of Key Players/Suppliers in 2017
Figure United States Inflammatory Bowel Disease Market Share of Top 3 Players/Suppliers
Figure United States Inflammatory Bowel Disease Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Inflammatory Bowel Disease Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Inflammatory Bowel Disease Product Category
Table United States Inflammatory Bowel Disease Sales (MT) by Region (2013-2018)
Table United States Inflammatory Bowel Disease Sales Share by Region (2013-2018)
Figure United States Inflammatory Bowel Disease Sales Share by Region (2013-2018)
Figure United States Inflammatory Bowel Disease Sales Market Share by Region in 2017
Table United States Inflammatory Bowel Disease Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Inflammatory Bowel Disease Revenue Share by Region (2013-2018)
Figure United States Inflammatory Bowel Disease Revenue Market Share by Region (2013-2018)
Figure United States Inflammatory Bowel Disease Revenue Market Share by Region in 2017
Table United States Inflammatory Bowel Disease Price (USD/Kg) by Region (2013-2018)
Table United States Inflammatory Bowel Disease Sales (MT) by Type (2013-2018)
Table United States Inflammatory Bowel Disease Sales Share by Type (2013-2018)
Figure United States Inflammatory Bowel Disease Sales Share by Type (2013-2018)
Figure United States Inflammatory Bowel Disease Sales Market Share by Type in 2017
Table United States Inflammatory Bowel Disease Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Inflammatory Bowel Disease Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Inflammatory Bowel Disease by Type (2013-2018)
Figure Revenue Market Share of Inflammatory Bowel Disease by Type in 2017
Table United States Inflammatory Bowel Disease Price (USD/Kg) by Types (2013-2018)
Figure United States Inflammatory Bowel Disease Sales Growth Rate by Type (2013-2018)
Table United States Inflammatory Bowel Disease Sales (MT) by Application (2013-2018)
Table United States Inflammatory Bowel Disease Sales Market Share by Application (2013-2018)
Figure United States Inflammatory Bowel Disease Sales Market Share by Application (2013-2018)
Figure United States Inflammatory Bowel Disease Sales Market Share by Application in 2017
Table United States Inflammatory Bowel Disease Sales Growth Rate by Application (2013-2018)
Figure United States Inflammatory Bowel Disease Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Abbvie Basic Information List
Table Abbvie Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Merck Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Merck Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Biogen Idec Basic Information List
Table Biogen Idec Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Merck & Company Basic Information List
Table Merck & Company Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Mitsubishi Tanabe Basic Information List
Table Mitsubishi Tanabe Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Salix Pharmaceuticals Basic Information List
Table Salix Pharmaceuticals Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Genentech Basic Information List
Table Genentech Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Genentech Inflammatory Bowel Disease Sales Growth Rate (2013-2018)
Figure Genentech Inflammatory Bowel Disease Sales Market Share in United States (2013-2018)
Figure Genentech Inflammatory Bowel Disease Revenue Market Share in United States (2013-2018)
Table Shire Basic Information List
Table UCB Basic Information List
Table Akebia Therapeutics Basic Information List
Table Amgen Basic Information List
Table ChemoCentryx Basic Information List
Table Novartis Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Celltrion Basic Information List
Table Novo Nordisk Basic Information List
Table Ferring Pharmaceuticals Basic Information List
Table Galapagos Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inflammatory Bowel Disease
Figure Manufacturing Process Analysis of Inflammatory Bowel Disease
Figure Inflammatory Bowel Disease Industrial Chain Analysis
Table Raw Materials Sources of Inflammatory Bowel Disease Major Players/Suppliers in 2017
Table Major Buyers of Inflammatory Bowel Disease
Table Distributors/Traders List
Figure United States Inflammatory Bowel Disease Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure United States Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Inflammatory Bowel Disease Price (USD/Kg) Trend Forecast (2018-2025)
Table United States Inflammatory Bowel Disease Sales Volume (MT) Forecast by Type (2018-2025)
Figure United States Inflammatory Bowel Disease Sales Volume (MT) Forecast by Type (2018-2025)
Figure United States Inflammatory Bowel Disease Sales Volume (MT) Forecast by Type in 2025
Table United States Inflammatory Bowel Disease Sales Volume (MT) Forecast by Application (2018-2025)
Figure United States Inflammatory Bowel Disease Sales Volume (MT) Forecast by Application (2018-2025)
Figure United States Inflammatory Bowel Disease Sales Volume (MT) Forecast by Application in 2025
Table United States Inflammatory Bowel Disease Sales Volume (MT) Forecast by Region (2018-2025)
Table United States Inflammatory Bowel Disease Sales Volume Share Forecast by Region (2018-2025)
Figure United States Inflammatory Bowel Disease Sales Volume Share Forecast by Region (2018-2025)
Figure United States Inflammatory Bowel Disease Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories